Venous Stasis Ulcer VSU Kare® - 60 tablets - 60 day supply
According to the American College of Phlebology, epidemiologic studies have found that the prevalence of leg ulceration in adults, either active or healed, is about 1-2%. This is quite a number, suggesting that there are some 3 million to 6 million adults in the United States with venous stasis ulcers (venous ulcers). Depending on the study, venous stasis ulcers are 1.5 to 3 times more common in women. They occur rarely before the age of forty and are found in as many as 3.4 % of patients older than 80 years of age. Venous stasis ulcers have been diagnosed and treated in patients as young as 20 years old!
Venous stasis ulcers are not only debilitating but costly. In one U.S. study, the cost per year per patient with a venous stasis ulcer exceeds $ 40,000. The total economic impact of venous stasis ulcers on the healthcare system in the U.S. is 1 billion dollars per year according to data supporting the Affordable Health Care Act (Obama Care). Very rarely are patients able to work as these open wounds (venous ulcers) require constant care and cause significant disability and pain.
Over 80 % of patients with venous stasis ulcers have limited mobility. According to studies reported in the medical literature, in terms of quality of life, the open wounds cause more concern for patients than symptoms of pain, itching, anxiety, social isolation and reduced ability to perform their daily routine. At least, most venous stasis ulcers require daily or twice daily wound dressing changes. In advanced healthcare environments and systems, patients with venous stasis ulcers are seen by home health care nurses at least once weekly. Physicians who are specialized in wound care also supervise the evolution of these healing wounds once monthly and more frequently when they are infected or have significant necrotic tissue that requires debridement.
A variety of etiologies can cause leg ulcers, but the majority of patients with venous stasis ulcers have venous reflux disease. It is estimated that venous reflux disease is 5-7 TIMES more common than arterial insufficiency (peripheral arterial disease) and can be considered an endemic disease.
Patients with venous insufficiency can wear stockings to help support the failing valves and/or have veins stripping or endovenous ablation procedures such as VenaCure EVLT, VNUS FAST Closure or ClariVein. No matter which treatment option is chosen, compression stockings need to be worn to reduce the likelihood of developing more vein problems in the future.
Bioflavonoids have been shown to treat venous insufficiency - read Dr. Karamanoukian's book about bioflavonoids for FREE - The Health Benefits of Citrus Bioflavonoids. Go to e books section on www.VeinsVeinsVeins.com
Features and Benefits
Superficial venous reflux and perforator venous reflux are involved in most patients with venous stasis ulcers and those with recalcitrant and recurrent ulceration. Two Board Certified Phlebologists (Vein Specialists) and a Plastic and Reconstructive Surgeon have developed this proprietary blend of phytoceuticals that treat the underlying problem associated with the development of venous stasis ulcers, which is chronic venous insufficiency (CVI). VSU Kare® protects venous valves from the destructive effects of white blood cell induced inflammation and damage, leading to a healthy venous physiology and wound milieu that favors accelerated healing. By enhancing the integrity of the microcirculation and lymphatic system, the individual components of VSU Kare® also have protective activity against the development of venous stasis ulcers.
Diosmin, Hesperidin, Grape Seed Extract and Rutin (proprietary doses and combination) which is trademarked with patent pending.
Uberceuticals® formulas are proprietary, meaning that the herbs and minerals are compounded to our specifications and patented in a manner that cannot be used or duplicated by other companies or third party manufacturers. Other lesser brands may formulate products with similar ingredients, but the ratios of ingredients in our product are clinically tested and cannot be duplicated. Uberceuticals® is the Leader in Vein Care Science.